Re-transplantation
|
0.035
|
Re-transplantation
|
0.028
|
Donor age
|
0.010
|
Life-support
|
0.025
|
HCV (d) serology status
|
0.025
|
Re-transplantation
|
0.009
|
Pre-treatment status ICU (a)
|
0.023
|
Life-support
|
0.024
|
Life support
|
0.007
|
Donor type DCD (b)
|
0.023
|
Donor age
|
0.023
|
HCV (d) serology status
|
0.007
|
Race Black (c)
|
0.022
|
Diabetes
|
0.021
|
Pre-treatment status
|
0.006
|
HCV (d) serology status
|
0.022
|
Pre-treatment status ICU (a)
|
0.020
|
Recipient age
|
0.004
|
Diabetes
|
0.020
|
Working income
|
0.020
|
Aetiology
|
0.003
|
Donor age
|
0.020
|
Race Black (c)
|
0.019
|
log(Last serum creatinine)
|
0.003
|
Working income
|
0.018
|
Previous abdominal surgery
|
0.015
|
Functional status
|
0.002
|
Functional status Total assistance (e)
|
0.017
|
Donor pre-recovery diuretics
|
0.015
|
log(Total cold ischemic time)
|
0.002
|
Aetiology HCV
|
0.017
|
Aetiology Cholestatic
|
0.011
|
Race
|
0.002
|
Hypertensive bleeding
|
0.017
|
Functional status Total assistance (e)
|
0.015
|
Diabetes
|
0.002
|